Carol Wadham

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.

Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.

Journal: Blood

Published: June 06, 2025

Enhanced Detection of Splice-Altering Variants in Hematologic Malignancies Using Targeted RNA-Sequencing Data.

Enhanced Detection of Splice-Altering Variants in Hematologic Malignancies Using Targeted RNA-Sequencing Data.

Journal: The Journal of molecular diagnostics : JMD

Published: February 25, 2025

Beyond BCR::ABL1-The Role of Genomic Analyses in the Management of CML.

Beyond BCR::ABL1-The Role of Genomic Analyses in the Management of CML.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 18, 2023

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.

Journal: Haematologica

Published: October 06, 2022

Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication.

Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication.

Journal: Current hematologic malignancy reports

Published: July 07, 2022

RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.

RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.

Journal: The Journal of molecular diagnostics : JMD

Published: December 05, 2021

In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.

In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.

Journal: EMBO molecular medicine

Published: May 28, 2021

Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2.

Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 12, 2020

CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.

CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.

Journal: British journal of cancer

Published: February 01, 2020

Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia.

Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia.

Journal: Leukemia

Published: November 04, 2019

Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.

Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.

Journal: International journal of cancer

Published: February 27, 2019

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.

Journal: Cancer biology & therapy

Published: October 10, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026